SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-066932
Filing Date
2024-05-31
Accepted
2024-05-31 08:30:12
Documents
12
Period of Report
2024-05-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K itrm-20240529.htm   iXBRL 8-K 50851
2 EX-99.1 itrm-ex99_1.htm EX-99.1 15612
  Complete submission text file 0000950170-24-066932.txt   191473

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20240529.xsd EX-101.SCH 26762
15 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20240529_htm.xml XML 4891
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 241007790
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)